levocarnitine and tirzepatide ✨ You deserve to expect more, we deliver! ✨ We're excited to tirzepatide l-carnitine compound l carnitine

According to the Summary of Product Characteristics (SmPC), these include: Nausea (very common: may affect more than 1 in 10 people) Diarrhoea and constipation (very common) Vomiting and abdominal pain (very common) Decreased appetite and dyspepsia (very common) Most gastrointestinal adverse effects are mild to moderate in severity and tend to diminish over time as the body adjusts to treatment

This dose is specific to that indication

Syahrir M, Andayani YD, Norman D, Maksudin ES, Muharramah PF, Kgs MR,

Additionally, the superiority of GLP-1RAs compared to placebo in the primary endpoint of 3-MACE were found with liraglutide in the LEADER trial (HR 0.87

This can give you a clear picture of whether or not the medication is having any effect on your blood sugar

Each question is a 7-item Likert scale ranging from strongly disagree to strongly agree. Craving score was calculated by averaging each items rating, with higher scores indicating greater craving